Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Harvard Bioscience Completes Genomics Solutions Acquisition

Oct. 28, 2002

By Aaron Lorenzo

OSI Drops Diabetes Program, Puts Full Focus On Oncology

Oct. 25, 2002

By Aaron Lorenzo

OSI Drops Diabetes Program, Puts Full Focus On Oncology

Oct. 25, 2002

By Aaron Lorenzo

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Oct. 24, 2002

By Aaron Lorenzo

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Oct. 24, 2002

By Aaron Lorenzo

Incara Divests Liver Program Via Sale To Vesta Therapeutics

Oct. 23, 2002

By Aaron Lorenzo

Incara Divests Liver Program Via Sale To Vesta Therapeutics

Oct. 23, 2002

By Aaron Lorenzo

ICOS, Texas Biotechnology Plan FDA Meeting On PAH Drug

Oct. 22, 2002

By Aaron Lorenzo

ICOS, Texas Biotechnology Plan FDA Meeting On PAH Drug

Oct. 22, 2002

By Aaron Lorenzo

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Oct. 8, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...